Inactief instrument

Andere talen Innate Immunotherapeutics Ltd Australian S.E.

Aandelen

AU000000IIL6

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2024	30/05
Amplia Therapeutics Completes AU$4.27 Million Entitlement Offer; Shares Up 9%	15/05
Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing	16/04
Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II	27/03
Amplia Therapeutics Updates on Pancreatic Cancer Trial; Phase-Two Recruitment Ongoing; Shares Up 3%	27/03
Amplia Therapeutics moves to next phase of pancreatic cancer treatment trial	14/02
Amplia Therapeutics Secures US FDA Clearance for Proposed Pancreatic Cancer Trial	18/01
Amplia Therapeutics Limited Announces FDA Clearance of it's IND for Pancreatic Cancer Trial in US	18/01
Amplia Therapeutics Doses First Patient in Phase 2A Pancreatic Cancer Trial	17/01
Amplia Therapeutics Secures South Korean Regulatory Approval for Pancreatic Cancer Trial; Shares Up 3%	04/12
Amplia Therapeutics Limited Reports Earnings Results for the Half Year Ended September 30, 2023	20/11
Amplia Therapeutics Receives AU$2.4 Million R&D Tax Rebate	19-10-23
Amplia Therapeutics Appoints CFO	25-09-23
Amplia Therapeutics Limited Announces Chief Financial Officer Changes	25-09-23
Amplia Therapeutics Gets Nod to Name Drug AMP945 Narmafotinib	23-06-23
Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30-05-23
Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt	30-05-23
Amplia secures funding to assess AMP945 topical applications	22-05-23
Amplia Therapeutics to Enter Research Collaboration with CSIRO; Shares Rise 7%	22-05-23
Amplia Receives Grant to Collaborate with CSIRO	22-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Innate Immunotherapeutics Ltd Australian S.E.

Aandelen

AU000000IIL6

Andere talen

Filters